Europe Medical Exoskeleton Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Europe Medical Exoskeleton Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Europe Medical Exoskeleton Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Europe Medical Exoskeleton Market Regional Analysis

6.2 Europe Medical Exoskeleton Market Revenue 2020-2031 (US$ Million)

6.3 Europe Medical Exoskeleton Market Forecast Analysis

7. Europe Medical Exoskeleton Market Analysis – by Component

7.1 Hardware

7.1.1 Overview
7.1.2 Hardware: Europe Medical Exoskeleton Market – Revenue and Forecast, 2020-2031 (US$ Million)

7.2 Software

7.2.1 Overview
7.2.2 Software: Europe Medical Exoskeleton Market – Revenue and Forecast, 2020-2031 (US$ Million)

8. Europe Medical Exoskeleton Market Analysis – by Type

8.1 Powered Exoskeleton

8.1.1 Overview
8.1.2 Powered Exoskeleton: Europe Medical Exoskeleton Market – Revenue and Forecast, 2020-2031 (US$ Million)

8.2 Passive Exoskeleton

8.2.1 Overview
8.2.2 Passive Exoskeleton: Europe Medical Exoskeleton Market – Revenue and Forecast, 2020-2031 (US$ Million)

9. Europe Medical Exoskeleton Market Analysis – by Extremity

9.1 Lower Body Exoskeleton

9.1.1 Overview
9.1.2 Lower Body Exoskeleton: Europe Medical Exoskeleton Market – Revenue and Forecast, 2020-2031 (US$ Million)

9.2 Upper Body Exoskeleton

9.2.1 Overview
9.2.2 Upper Body Exoskeleton: Europe Medical Exoskeleton Market – Revenue and Forecast, 2020-2031 (US$ Million)

9.3 Full Body Exoskeleton

9.3.1 Overview
9.3.2 Full Body Exoskeleton: Europe Medical Exoskeleton Market – Revenue and Forecast, 2020-2031 (US$ Million)

10. Europe Medical Exoskeleton Market Analysis – by Application

10.1 Spinal Cord Injury

10.1.1 Overview
10.1.2 Spinal Cord Injury: Europe Medical Exoskeleton Market – Revenue and Forecast, 2020-2031 (US$ Million)

10.2 Multiple Sclerosis

10.2.1 Overview
10.2.2 Multiple Sclerosis: Europe Medical Exoskeleton Market – Revenue and Forecast, 2020-2031 (US$ Million)

10.3 Stroke

10.3.1 Overview
10.3.2 Stroke: Europe Medical Exoskeleton Market – Revenue and Forecast, 2020-2031 (US$ Million)

10.4 Cerebral Palsy

10.4.1 Overview
10.4.2 Cerebral Palsy: Europe Medical Exoskeleton Market – Revenue and Forecast, 2020-2031 (US$ Million)

10.5 Parkinson\'s Disease

10.5.1 Overview
10.5.2 Parkinson\'s Disease: Europe Medical Exoskeleton Market – Revenue and Forecast, 2020-2031 (US$ Million)

11. Europe Medical Exoskeleton Market – Europe Analysis

11.1 Overview

11.2 Europe

11.2.1 Europe Medical Exoskeleton Market Breakdown, by Key Country, 2023 and 2031 (%)
11.2.1.1 Europe Medical Exoskeleton Market – Revenue and Forecast Analysis – by Country
11.2.1.1 UK: Europe Medical Exoskeleton Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.1.1 UK: Europe Medical Exoskeleton Market Breakdown, by Component
11.2.1.1.2 UK: Europe Medical Exoskeleton Market Breakdown, by Type
11.2.1.1.3 UK: Europe Medical Exoskeleton Market Breakdown, by Extremity
11.2.1.1.4 UK: Europe Medical Exoskeleton Market Breakdown, by Application

11.2.1.2 Germany: Europe Medical Exoskeleton Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.2.1 Germany: Europe Medical Exoskeleton Market Breakdown, by Component
11.2.1.2.2 Germany: Europe Medical Exoskeleton Market Breakdown, by Type
11.2.1.2.3 Germany: Europe Medical Exoskeleton Market Breakdown, by Extremity
11.2.1.2.4 Germany: Europe Medical Exoskeleton Market Breakdown, by Application

11.2.1.3 France: Europe Medical Exoskeleton Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.3.1 France: Europe Medical Exoskeleton Market Breakdown, by Component
11.2.1.3.2 France: Europe Medical Exoskeleton Market Breakdown, by Type
11.2.1.3.3 France: Europe Medical Exoskeleton Market Breakdown, by Extremity
11.2.1.3.4 France: Europe Medical Exoskeleton Market Breakdown, by Application

11.2.1.4 Russia: Europe Medical Exoskeleton Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.4.1 Russia: Europe Medical Exoskeleton Market Breakdown, by Component
11.2.1.4.2 Russia: Europe Medical Exoskeleton Market Breakdown, by Type
11.2.1.4.3 Russia: Europe Medical Exoskeleton Market Breakdown, by Extremity
11.2.1.4.4 Russia: Europe Medical Exoskeleton Market Breakdown, by Application

11.2.1.5 Italy: Europe Medical Exoskeleton Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.5.1 Italy: Europe Medical Exoskeleton Market Breakdown, by Component
11.2.1.5.2 Italy: Europe Medical Exoskeleton Market Breakdown, by Type
11.2.1.5.3 Italy: Europe Medical Exoskeleton Market Breakdown, by Extremity
11.2.1.5.4 Italy: Europe Medical Exoskeleton Market Breakdown, by Application

11.2.1.6 Rest of Europe: Europe Medical Exoskeleton Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.6.1 Rest of Europe: Europe Medical Exoskeleton Market Breakdown, by Component
11.2.1.6.2 Rest of Europe: Europe Medical Exoskeleton Market Breakdown, by Type
11.2.1.6.3 Rest of Europe: Europe Medical Exoskeleton Market Breakdown, by Extremity
11.2.1.6.4 Rest of Europe: Europe Medical Exoskeleton Market Breakdown, by Application

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 Ekso Bionics Holdings Inc\r\n

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 Lifeward, Inc\r\n

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 ExoAtlet\r\n

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 Cyberdyne Inc\r\n

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 BIONIK\r\n

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 B-Temia Inc\r\n

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 Hocoma AG\r\n

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 Wearable Robotics SRL\r\n

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

14.9 Myomo Inc\r\n

14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments

14.10 Rex Bionics Ltd.

14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

Europe Medical Exoskeleton Market